Cargando…

Exploring public knowledge and perceptions regarding per os OTC pain-relieving medications: the case of paracetamol (acetaminophen)

BACKGROUND: Over-the-counter medications (OTC) are safe and effective when patients follow the patient’s information leaflet (PIL) instructions and/or the instructions given by healthcare professionals (HCPs). However, OTC medications could be harmful and unsafe when individuals do not follow the gi...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrides, Michael, Peletidi, Aliki, Petrou, Christos, Nena, Evangelia, Papavasili, Maria, Constantinidis, Theodoros, Kontogiorgis, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360319/
https://www.ncbi.nlm.nih.gov/pubmed/37475043
http://dx.doi.org/10.1186/s40545-023-00598-1
_version_ 1785076078755184640
author Petrides, Michael
Peletidi, Aliki
Petrou, Christos
Nena, Evangelia
Papavasili, Maria
Constantinidis, Theodoros
Kontogiorgis, Christos
author_facet Petrides, Michael
Peletidi, Aliki
Petrou, Christos
Nena, Evangelia
Papavasili, Maria
Constantinidis, Theodoros
Kontogiorgis, Christos
author_sort Petrides, Michael
collection PubMed
description BACKGROUND: Over-the-counter medications (OTC) are safe and effective when patients follow the patient’s information leaflet (PIL) instructions and/or the instructions given by healthcare professionals (HCPs). However, OTC medications could be harmful and unsafe when individuals do not follow the given instructions and/or when their understanding about the proper use of OTC medications is incorrect. This study aimed to investigate the knowledge and perceptions of people regarding paracetamol use in the Republic of Cyprus. METHODS: This cross-sectional study, which belongs to quantitative research methods, included participants visiting community pharmacies in the following three cities of the Republic of Cyprus: Nicosia, Limassol and Larnaca. Participation in the study was voluntary and anonymous. Participants responded to the survey-based questionnaire, which concerned their knowledge and views on paracetamol use. After the data collection, responses were tabulated and analysed statistically. RESULTS: The original compound was shown to be more well-known compared to generics. A notable percentage of respondents—ranging between 13.0% (N = 49) and 29.8% (N = 112)—answered incorrectly that broadly used non-steroidal anti-inflammatory drugs (NSAIDs) contain paracetamol. Furthermore, a remarkable percentage of respondents (71.5%, N = 269 and 50.3%, N = 189, respectively) falsely believed that two widely used combination products in the market of Cyprus (Paracetamol and Hyoscine-N-butylbromide; Paracetamol and Codeine and Caffeine) did not contain paracetamol. A notable percentage of participants (27.6%, N = 100) believed that paracetamol causes low toxicity. More than a third of the respondents (40.2%, N = 149) drink alcohol together with or slightly after consuming paracetamol products. This viewpoint was linked with the participants’ attitude towards consuming paracetamol medications after drinking alcohol (OR for consuming alcohol versus not consuming alcohol 0.100, 95% CI 0.044–0.225, p = 0.000). CONCLUSIONS: To the best of our knowledge, this is the first study conducted in the Republic of Cyprus on this topic. Paracetamol is frequently consumed by individuals, both in its generic and original forms. However, the study showed that respondents often misperceive NSAIDs and paracetamol-containing medications. In addition, it is identified that there is a lack of education among people about the safe and effective use of paracetamol, namely, indications, potential side effects, maximum daily dose, alcohol consumption, and the potential risks of hepatotoxicity. The study contributed to the current published literature as it showed that there is a significant public health issue, for which appropriate measures can be established by the respective Authorities of Cyprus. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40545-023-00598-1.
format Online
Article
Text
id pubmed-10360319
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103603192023-07-22 Exploring public knowledge and perceptions regarding per os OTC pain-relieving medications: the case of paracetamol (acetaminophen) Petrides, Michael Peletidi, Aliki Petrou, Christos Nena, Evangelia Papavasili, Maria Constantinidis, Theodoros Kontogiorgis, Christos J Pharm Policy Pract Research BACKGROUND: Over-the-counter medications (OTC) are safe and effective when patients follow the patient’s information leaflet (PIL) instructions and/or the instructions given by healthcare professionals (HCPs). However, OTC medications could be harmful and unsafe when individuals do not follow the given instructions and/or when their understanding about the proper use of OTC medications is incorrect. This study aimed to investigate the knowledge and perceptions of people regarding paracetamol use in the Republic of Cyprus. METHODS: This cross-sectional study, which belongs to quantitative research methods, included participants visiting community pharmacies in the following three cities of the Republic of Cyprus: Nicosia, Limassol and Larnaca. Participation in the study was voluntary and anonymous. Participants responded to the survey-based questionnaire, which concerned their knowledge and views on paracetamol use. After the data collection, responses were tabulated and analysed statistically. RESULTS: The original compound was shown to be more well-known compared to generics. A notable percentage of respondents—ranging between 13.0% (N = 49) and 29.8% (N = 112)—answered incorrectly that broadly used non-steroidal anti-inflammatory drugs (NSAIDs) contain paracetamol. Furthermore, a remarkable percentage of respondents (71.5%, N = 269 and 50.3%, N = 189, respectively) falsely believed that two widely used combination products in the market of Cyprus (Paracetamol and Hyoscine-N-butylbromide; Paracetamol and Codeine and Caffeine) did not contain paracetamol. A notable percentage of participants (27.6%, N = 100) believed that paracetamol causes low toxicity. More than a third of the respondents (40.2%, N = 149) drink alcohol together with or slightly after consuming paracetamol products. This viewpoint was linked with the participants’ attitude towards consuming paracetamol medications after drinking alcohol (OR for consuming alcohol versus not consuming alcohol 0.100, 95% CI 0.044–0.225, p = 0.000). CONCLUSIONS: To the best of our knowledge, this is the first study conducted in the Republic of Cyprus on this topic. Paracetamol is frequently consumed by individuals, both in its generic and original forms. However, the study showed that respondents often misperceive NSAIDs and paracetamol-containing medications. In addition, it is identified that there is a lack of education among people about the safe and effective use of paracetamol, namely, indications, potential side effects, maximum daily dose, alcohol consumption, and the potential risks of hepatotoxicity. The study contributed to the current published literature as it showed that there is a significant public health issue, for which appropriate measures can be established by the respective Authorities of Cyprus. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40545-023-00598-1. BioMed Central 2023-07-20 /pmc/articles/PMC10360319/ /pubmed/37475043 http://dx.doi.org/10.1186/s40545-023-00598-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Petrides, Michael
Peletidi, Aliki
Petrou, Christos
Nena, Evangelia
Papavasili, Maria
Constantinidis, Theodoros
Kontogiorgis, Christos
Exploring public knowledge and perceptions regarding per os OTC pain-relieving medications: the case of paracetamol (acetaminophen)
title Exploring public knowledge and perceptions regarding per os OTC pain-relieving medications: the case of paracetamol (acetaminophen)
title_full Exploring public knowledge and perceptions regarding per os OTC pain-relieving medications: the case of paracetamol (acetaminophen)
title_fullStr Exploring public knowledge and perceptions regarding per os OTC pain-relieving medications: the case of paracetamol (acetaminophen)
title_full_unstemmed Exploring public knowledge and perceptions regarding per os OTC pain-relieving medications: the case of paracetamol (acetaminophen)
title_short Exploring public knowledge and perceptions regarding per os OTC pain-relieving medications: the case of paracetamol (acetaminophen)
title_sort exploring public knowledge and perceptions regarding per os otc pain-relieving medications: the case of paracetamol (acetaminophen)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360319/
https://www.ncbi.nlm.nih.gov/pubmed/37475043
http://dx.doi.org/10.1186/s40545-023-00598-1
work_keys_str_mv AT petridesmichael exploringpublicknowledgeandperceptionsregardingperosotcpainrelievingmedicationsthecaseofparacetamolacetaminophen
AT peletidialiki exploringpublicknowledgeandperceptionsregardingperosotcpainrelievingmedicationsthecaseofparacetamolacetaminophen
AT petrouchristos exploringpublicknowledgeandperceptionsregardingperosotcpainrelievingmedicationsthecaseofparacetamolacetaminophen
AT nenaevangelia exploringpublicknowledgeandperceptionsregardingperosotcpainrelievingmedicationsthecaseofparacetamolacetaminophen
AT papavasilimaria exploringpublicknowledgeandperceptionsregardingperosotcpainrelievingmedicationsthecaseofparacetamolacetaminophen
AT constantinidistheodoros exploringpublicknowledgeandperceptionsregardingperosotcpainrelievingmedicationsthecaseofparacetamolacetaminophen
AT kontogiorgischristos exploringpublicknowledgeandperceptionsregardingperosotcpainrelievingmedicationsthecaseofparacetamolacetaminophen